Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 17.00 3.58 10.76 0.00 0.00 21.38
P/S ratio
6.59 6.39 3.82 4.85 4.66 4.57 4.61 4.36 2.01 1.84
P/FCF ratio
0.00 0.00 0.00 545.92 10.87 7.23 6.92 10.53 6.82 4.29
P/Operating CF
(94.04) (206.82) 142.87 75.30 35.25 29.30 23.92 53.83 46.32 7.31
P/B ratio
27.05 193.50 0.00 0.00 28.99 3.12 2.90 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 29.36 3.13 2.91 0.00 0.00 0.00
EV/Sales
6.81 6.97 4.51 5.39 4.84 4.21 3.98 5.73 3.98 3.09
EV/EBITDA
0.00 0.00 0.00 18.36 12.87 7.46 6.50 0.00 14.72 9.11
EV/Operating CF
(71.94) (20.65) (22.07) 215.15 11.16 6.66 5.98 13.82 13.52 7.20
EV/FCF
(62.37) (20.11) (22.45) 606.61 11.29 6.66 5.98 13.84 13.54 7.20
Quick Ratio
4.06 4.60 2.14 7.22 15.13 4.55 30.28 0.80 4.39 1.08
Current Ratio
4.17 4.72 2.23 7.50 15.41 4.61 30.58 0.84 4.69 1.13
Net Debt/EBITDA
(1.66) (66.00) (1.73) 1.84 0.47 (0.64) (1.03) (0.64) 5.21 3.68
Debt/Assets
52.52% 66.06% 124.63% 101.55% 77.47% 41.96% 36.28% 148.14% 166.42% 147.31%
Debt/Equity
5.59 40.63 (2.11) (4.39) 6.92 0.78 0.61 (2.02) (1.94) (2.23)
Asset Turnover
0.41 0.45 0.74 1.17 0.81 0.49 0.37 0.56 0.86 0.79
Operating CF/Net income
0.32 0.86 0.25 0.50 1.59 0.50 1.56 (0.18) 117.67 5.29
Capex/Depreciation
(9.23) (0.21) 0.10 (1.24) (0.52) (0.17) (0.10) (0.17) (0.07) (0.02)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(100.97%) (305.46%) 302.77% (14.85%) (693.71%) 158.09% 27.83% (654.88%) (0.27%) (8.53%)
ROA
(12.30%) (17.78%) (60.22%) 5.85% 22.07% 62.68% 15.72% (127.54%) 0.21% 6.42%
ROIC
(24.14%) (5.09%) (218.71%) 54.61% 67.89% 31.74% 39.69% (227.77%) 29.99% 57.33%
Return on Tangible Assets
(26.39%) (44.49%) (182.69%) 7.73% 22.47% 89.40% 22.99% 2,692.16% 0.59% 67.91%
Average Days of Receivables
86.41 100.54 85.24 99.89 114.65 100.60 102.64 106.45 85.05 57.61
Research and Development Expense of Revenue
50.92% 29.55% 29.15% 26.85% 22.61% 17.02% 10.78% 273.65% 31.71% 32.12%
Selling, General and Administrative Expense of Revenue
63.25% 77.51% 63.37% 40.25% 35.94% 26.86% 28.25% 35.76% 41.06% 27.78%
Intangible Assets out of Total Assets
0.24 0.27 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01
Share Based Compensation of Revenue
10.67% 10.36% 11.69% 7.30% 8.00% 5.39% 6.59% 7.23% 8.49% 5.82%
Graham Net Nets
(0.15) (0.15) (0.20) (0.09) 0.00 0.12 0.18 (0.30) (0.67) (0.71)
Graham Number
0.00 0.00 7.32 1.17 2.43 16.55 10.41 17.98 0.20 0.00
Earnings Yield
(4.50%) (6.25%) (21.31%) (0.77%) 5.88% 27.96% 9.29% (51.97%) (0.02%) 4.68%
Free Cash Flow Yield
(1.66%) (5.43%) (5.26%) 0.18% 9.20% 13.83% 14.45% 9.50% 14.67% 23.29%
Revenue per Share
1.89 2.00 2.27 2.75 2.44 2.55 2.66 2.85 2.21 1.83
Operating CF per Share
(0.18) (0.68) (0.46) 0.07 1.06 1.61 1.77 1.18 0.65 0.79
Capex per Share
(0.72) (0.02) 0.01 (0.04) (0.01) 0.00 0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.90) (0.69) (0.46) 0.02 1.05 1.61 1.77 1.18 0.65 0.78
Cash per Share
2.11 1.49 1.14 1.14 2.29 3.83 4.26 0.59 0.56 1.33
Shareholders Equity per Share
0.46 0.07 (1.29) (0.60) 0.39 3.73 4.23 (2.23) (1.89) (1.62)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.46 0.07 (1.29) (0.60) 0.39 3.73 4.23 (2.23) (1.89) (1.62)
Free Cash Flow
(129.91) (103.42) (69.67) 3.80 166.99 261.63 273.63 183.15 103.41 127.01
Working Capital
289.05 245.57 146.91 265.92 463.67 583.53 755.10 (42.81) 143.52 31.96
Capital Expenditures
(103.98) (2.67) 1.21 (6.92) (1.84) (0.26) (0.14) (0.27) (0.14) (0.03)
Net Current Asset Value
(262.92) (284.23) (261.99) (189.15) (0.76) 224.21 332.49 (584.08) (469.87) (384.56)
EV/EBIT
0.00 0.00 0.00 19.21 13.19 7.51 6.53 0.00 15.03 9.29
Capex to Sales
0.38 0.01 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Net Profit Margin
(29.83%) (39.20%) (81.46%) 5.02% 27.26% 127.72% 42.64% (226.37%) 0.25% 8.11%
Price to Operating Income
0.00 0.00 0.00 17.29 12.70 8.15 7.57 0.00 7.57 5.54
Other line items
Depreciation/Fixed assets
0.55 0.73 1.56 0.45 0.40 0.20 0.23 0.28 0.45 0.55
Cash ROIC
(6.24%) (18.69%) (20.04%) (0.34%) 18.59% 14.96% 15.65% 40.08% 26.68% 22.97%
Accounts Receivable Turnover
4.59 4.06 4.25 4.32 3.25 3.50 3.58 3.62 3.33 4.60
Accounts Payable Turnover
0.14 1.13 2.12 2.34 1.02 1.91 2.00 0.00 0.00 0.00
Inventory Turnover
0.62 21.03 (922.56) (302.22) 4.84 0.00 0.00 — — —
Average Days of Payables
3,459.10 305.00 165.96 83.89 76.93 224.08 124.33 0.00 0.00 0.00
Days of Inventory on Hand
211.22 14.05 (8.98) 9.91 75.42 0.00 0.00 — — —
Average Receivables
59.69 73.51 81.55 99.10 119.80 118.20 114.75 122.29 105.50 64.32
Average Payables
13.15 16.83 15.42 10.19 3.07 0.80 0.71 4.16 4.98 2.51
Average Inventory
3.02 0.91 (0.04) (0.08) 0.65 — — — — —
Average Assets
664.47 657.75 468.86 367.40 480.99 843.08 1,113.72 785.80 410.99 373.90
Average Common Equity
80.92 38.28 (93.26) (144.81) (15.31) 334.28 629.14 153.04 (323.81) (281.58)

Fold the line items

Columns are period end dates